dev.PILOTforPulmonary.orgdev.PILOTforPulmonary.orgdev.PILOTforPulmonary.org

 x 

0 Activities
0 Activities
  • No Saved Activities
  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar

    Search Education

    Latest Education

    No image set

    A Collaborative Approach to IPF Management

    No image set

    Practical Solutions to SSc-ILD Treatment

    No image set

    Post COVID-19 and Patients With and Without Pre-existing ILD

    Menu Ad
  • Register
  • Contact Us
  • Login

    Login

    Create an account
    • Forgot your password?

 

Jointly Accredited Provider

Search

  • Credit Type
    • CME (AMA PRA Category 1 Credit)
    • MOC (Maintenance of Certification)
  • Disease Area
    • Alpha-1 Antitrypsin Deficiency (AATD)
    • Asthma
    • Bronchiectasis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • COVID-19
    • Cystic Fibrosis (CF)
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Interstitial Lung Disease (ILD)
    • Non-Small Cell Lung Cancer (NSCLC)
    • Nontuberculous Mycobacteria (NTM)
    • Pulmonary Hypertension (PH/PAH)
    • Radiology
    • Rheumatoid Conditions
  • Content Type
    • Animation
    • EXPLORE™
    • Interactive Cases
    • Podcast
    • Slides
    • Video
    • Webinar
  • Start
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • End
Page 3 of 5
Results 31 - 45 of 61
No image set
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
No image set
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
No image set
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
No image set
Updates on Current Treatment Options for RA-ILD
cc4
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
The SLE Consult: Diagnosis, Treatment Selection, Treatment Targets, and Monitoring
No image set
The SLE Consult: Lupus Nephritis, Patient-Clinician Communication, and Treatment Adherence
No image set
The Essential Role of Primary Care in SLE
No image set
A Step-by-Step Guide to Diagnosing SLE in the Primary Care Setting
9907-0006_shared
Engage Your Patients in Shared Decision-Making
9907-0005_cardio
Is It IPF or Cardiovascular Disease?
9907-0004_ip
Interstitial Pneumonia with Autoimmune Features
9907-0003_pf-ild
How to Identify Progressive Fibrosing ILD
9907-0002_ctd
When Is It a Connective Tissue Disease?
  • Start
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • End
Page 3 of 5

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA

Copyright © 2024 The France Foundation All Rights Reserved.
The France Foundation | Privacy Policy | Terms of Use

Search

  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar
  • Register
  • Contact Us
  • Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.
I accept